A next generation cancer therapy helps immune cells detect, and destroy cancer cells. This therapy works by evading two mechanisms that cancer cells use to evade macrophages, cells whose job it is to eat and destroy cancerous cells.
“The researchers [at Brigham and Women’s Hospital] tested the supramolecular therapeutic in animal models of aggressive forms of breast cancer and skin cancer, comparing their drug directly with a drug currently available in the clinic. Mice that were untreated formed large tumors by Day 10. Mice treated with currently available therapies showed decreased tumor growth. But mice treated with the new supramolecular therapy had complete inhibition of tumor growth. The team also reported an increase in survival and a significant reduction in metastatic nodes.”
This treatment is skill in the testing phases but it hold potential for future applications.